UK's first 'megalab' for covid-19 testing opens
It's expected to create 1,500 jobs
Last updated 24th May 2022
The UK’s first testing megalab has been opened in Leamington Spa.
The Rosalind Franklin laboratory will be processing hundreds of thousands of COVID-19 samples every day to rapidly detect new variants and help stop the spread of the virus.
As part of the UK’s NHS Test and Trace network, the laboratory is the biggest of its kind in the UK and will use cutting-edge technology to process even more tests and adopt the pioneering new genotype assay testing to quickly identify variants of concern and new mutations.
This will help the UK’s disease detectives take action to suppress outbreaks as society reopens, using tools such as surge testing.
The new laboratory will create up to 1,500 jobs when fully staffed, with over 300 people on-boarded already and over 700 more joining in the near future.
Around 60% of the staff hired so far coming from within 30 miles of the site.
Health and Social Care Secretary Sajid Javid said:
“The UK Health Security Agency is going to put us at the forefront of the global battle against COVID-19 and help us stay a step ahead of new and emerging future threats.
“Trailblazing technologies are going to be pivotal to delivering on this bold ambition and I’m delighted that today we are bolstering our capabilities in testing and genomic sequencing with the opening of the Rosalind Franklin Laboratory.
“This Laboratory will be one of the centrepieces of our efforts to manage this virus in the future, processing hundreds of thousands of positive COVID-19 tests a day to help us stop cases becoming outbreaks.
“Testing has already been instrumental in helping us control the virus and it is going to be essential to continue to protect ourselves and our communities in the months ahead. I’d urge everyone to take up our offer of free, twice weekly rapid testing.”
Chief Executive of the UKHSA Jenny Harries said:
“Our mission at the UK Health Security Agency is to learn the lessons of this global pandemic and positively harness them in how we prepare and steel ourselves against future health threats.
“The pandemic has provided us with clear evidence, on a daily basis, that you can only challenge viruses of this kind with the right testing and genomics infrastructure in place.
“The Rosalind Franklin Laboratory is going to be a critical scientific addition to how we manage this virus in the months ahead, arming us with data and intelligence on the spread of variants that will inform decision-making and ultimately, save lives.”